Cargando…
Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma
INTRODUCTION: Chromophobe renal cell carcinoma presents in early pathological stages with a lower risk of metastasis. However, aggressive features and metastasis can occur. A rare case of rapidly progressive disease with histological changes is presented. CASE PRESENTATION: A 56‐year‐old woman had a...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292175/ https://www.ncbi.nlm.nih.gov/pubmed/32743465 http://dx.doi.org/10.1002/iju5.12135 |
_version_ | 1783546055050133504 |
---|---|
author | Honda‐Takinami, Ruriko Ishibashi, Kei Onagi, Akifumi Tanji, Ryo Matsuoka, Kanako Hoshi, Seiji Koguchi, Tomoyuki Hata, Junya Yabe, Michihiro Sato, Yuichi Akaihata, Hidenori Kataoka, Masao Ogawa, Soichiro Haga, Nobuhiro Kojima, Yoshiyuki |
author_facet | Honda‐Takinami, Ruriko Ishibashi, Kei Onagi, Akifumi Tanji, Ryo Matsuoka, Kanako Hoshi, Seiji Koguchi, Tomoyuki Hata, Junya Yabe, Michihiro Sato, Yuichi Akaihata, Hidenori Kataoka, Masao Ogawa, Soichiro Haga, Nobuhiro Kojima, Yoshiyuki |
author_sort | Honda‐Takinami, Ruriko |
collection | PubMed |
description | INTRODUCTION: Chromophobe renal cell carcinoma presents in early pathological stages with a lower risk of metastasis. However, aggressive features and metastasis can occur. A rare case of rapidly progressive disease with histological changes is presented. CASE PRESENTATION: A 56‐year‐old woman had a right renal tumor with multiple lymph node metastases, and the pathological diagnosis of the biopsy specimens from the primary tumor was chromophobe renal cell carcinoma. After sunitinib treatment, the metastatic lymph node had decreased in size and the numbers of circulating tumor cells were decreased, consequently, cytoreductive nephrectomy was performed. However, rapid progression of lymph node metastases was observed. Histopathological examination showed that the renal tumor was diagnosed as spindle cell renal carcinoma. CONCLUSION: It appears that the primary tumor underwent epithelial‐mesenchymal transition; further tissue specimen collection and analysis might be needed. |
format | Online Article Text |
id | pubmed-7292175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72921752020-07-30 Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma Honda‐Takinami, Ruriko Ishibashi, Kei Onagi, Akifumi Tanji, Ryo Matsuoka, Kanako Hoshi, Seiji Koguchi, Tomoyuki Hata, Junya Yabe, Michihiro Sato, Yuichi Akaihata, Hidenori Kataoka, Masao Ogawa, Soichiro Haga, Nobuhiro Kojima, Yoshiyuki IJU Case Rep Case Reports INTRODUCTION: Chromophobe renal cell carcinoma presents in early pathological stages with a lower risk of metastasis. However, aggressive features and metastasis can occur. A rare case of rapidly progressive disease with histological changes is presented. CASE PRESENTATION: A 56‐year‐old woman had a right renal tumor with multiple lymph node metastases, and the pathological diagnosis of the biopsy specimens from the primary tumor was chromophobe renal cell carcinoma. After sunitinib treatment, the metastatic lymph node had decreased in size and the numbers of circulating tumor cells were decreased, consequently, cytoreductive nephrectomy was performed. However, rapid progression of lymph node metastases was observed. Histopathological examination showed that the renal tumor was diagnosed as spindle cell renal carcinoma. CONCLUSION: It appears that the primary tumor underwent epithelial‐mesenchymal transition; further tissue specimen collection and analysis might be needed. John Wiley and Sons Inc. 2020-01-10 /pmc/articles/PMC7292175/ /pubmed/32743465 http://dx.doi.org/10.1002/iju5.12135 Text en © 2020 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Honda‐Takinami, Ruriko Ishibashi, Kei Onagi, Akifumi Tanji, Ryo Matsuoka, Kanako Hoshi, Seiji Koguchi, Tomoyuki Hata, Junya Yabe, Michihiro Sato, Yuichi Akaihata, Hidenori Kataoka, Masao Ogawa, Soichiro Haga, Nobuhiro Kojima, Yoshiyuki Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma |
title | Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma |
title_full | Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma |
title_fullStr | Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma |
title_full_unstemmed | Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma |
title_short | Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma |
title_sort | spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292175/ https://www.ncbi.nlm.nih.gov/pubmed/32743465 http://dx.doi.org/10.1002/iju5.12135 |
work_keys_str_mv | AT hondatakinamiruriko spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT ishibashikei spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT onagiakifumi spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT tanjiryo spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT matsuokakanako spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT hoshiseiji spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT koguchitomoyuki spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT hatajunya spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT yabemichihiro spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT satoyuichi spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT akaihatahidenori spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT kataokamasao spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT ogawasoichiro spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT haganobuhiro spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma AT kojimayoshiyuki spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma |